Cancer
October 22, 2025
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
January 24, 2020
January 20, 2020
January 14, 2020
January 10, 2020
January 6, 2020
January 3, 2020
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community